Health Care & Life Sciences » Biotechnology | Genetic Signatures Ltd.

Genetic Signatures Ltd.

Genetic Signatures Ltd.
Stock Exchange Australian Stock Exchange
EPS
AUD0.03
Market Cap
AUD118.6 M
Shares Outstanding
104.03 M
Public Float
51.67 M

Profile

Address
7 Eliza Street
Newtown New South Wales (NSW) 2042
Australia
Employees -
Website http://www.geneticsignatures.com
Updated 07/08/2019
Genetic Signatures Ltd. engages in the research and commercialization of identifying individual genetic signatures to identify diseases and disabilities. Its molecular diagnostics, 3Base, provides high-volume hospital and pathology laboratories the ability to screen wide array of infectious pathogens. The firm also designs and manufactures suite of real-time polymerase chain reaction based products for the routine detection of infectious diseases under the EasyScreen brand.

Financials

View All
Created with Highcharts 5.0.14Genetic Signatures Ltd.Net Income. Fiscal year is July-June. All values AUD Thousands.1 7281 7282 6592 6593 0263 0262 6702 6703 2533 2532014201520162017201801k2k3k4k
Created with Highcharts 5.0.14Genetic Signatures Ltd.Sales/Revenue. Fiscal year is July-June. All values AUD Thousands.6846841 0431 0431 8251 8252 0372 0372 8402 84020142015201620172018050010001500200025003000

John R. Melki
Chief Executive Officer & Executive Director
Michael A. Aicher
Executive Director & Director-US Operations